Emmessar Biotech & Nutrition has informed that the Board of Directors at their meeting held today April 24, 2025 has transacted the following items of business: Financial Results: The Board of Directors approved the Audited Standalone Financial Results for the year ended 31.03.2025 along with the Statement of Assets and Liabilities for the year ended 31.03.2025 in the specified format along with the Auditors Report thereon. The above results have been reviewed by the Audit Committee and approved by the Board of Directors of the Company at their meeting(s) held on April 24, 2025. The company has enclosed are the Audited statements and declaration on Audit report with unmodified opinion. The Meeting commenced at 12:10 pm and concluded at 14.25 pm.
The above information is a part of company’s filings submitted to BSE.
